BNTX

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

03/23 05:00 am

BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls

03/10 03:39 pm

BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

03/10 02:48 pm

BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

03/10 08:40 am

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

03/04 09:14 am

Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

02/22 10:05 am

Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot

02/20 12:02 pm

Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

02/05 04:57 am

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer

01/28 09:00 am

BioNTech ernennt Kylie Jimenez zur neuen Personalvorständin

01/28 09:00 am

Nanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations

12/17 11:00 am

Pfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts

12/16 10:28 am

BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options

12/09 01:38 pm

BioNTechs und OncoC4s selektiver Treg-Modulatorkandidat Gotistobart erzielte klinisch relevanten Gesamtüberlebensvorteil bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge

12/06 04:30 pm

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

12/06 04:30 pm

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

12/03 10:01 am

2 Top Dividend Stocks to Buy and Hold

11/30 05:05 am

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

11/27 10:00 am

Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer

11/19 09:00 am

Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034

11/17 11:00 am

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

11/13 12:10 pm

Human Combinatorial Antibody Libraries Market to Surge USD 189.57 Million by 2034, Reports Towards Healthcare

10/24 11:00 am

Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

10/14 01:00 pm

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

10/08 10:15 am

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

10/01 06:13 pm

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

09/18 08:45 am

Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax

09/16 10:49 am

Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio?

09/14 11:01 am

Why BioNTech Stock Sank by More Than 7% Today

09/12 06:19 pm

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

09/08 02:13 pm

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

09/08 02:01 pm

Erste Zwischenergebnisse aus BioNTechs und BMS‘ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs

09/08 11:00 am

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

09/08 11:00 am

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

08/27 12:50 pm

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency

08/12 01:41 pm

Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034

08/05 06:00 am

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

08/04 10:32 am

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

08/01 08:44 am

Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - OncoTherapy Science, Inovio, BioNTech, Theravectys, and GlaxoSmithKline

07/30 04:31 am

Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

07/07 01:00 pm

Flu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges

06/20 10:59 am

Private-Public Deal Momentum Grows, Yet Megamergers Stay Elusive

06/18 02:26 pm

BioNTech’s CureVac Deal Signals Deep Pivot Toward mRNA Cancer Therapies

06/13 11:41 am

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal

06/12 11:07 am

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

06/12 06:45 am

Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug

06/02 10:14 am

Why BioNTech Stock Got Trounced on Tuesday

05/06 06:15 pm

Why Is Summit Therapeutics Stock Trading Higher On Monday?

04/28 01:00 pm

Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

04/25 05:05 pm

BioNTech Surpasses Q4 Revenue Estimates

03/10 08:42 am